REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 1 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $36,000 | +28.6% | 20,000 | 0.0% | 0.01% | +14.3% |
| Q2 2018 | $28,000 | -6.7% | 20,000 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $30,000 | -25.0% | 20,000 | 0.0% | 0.01% | -20.0% |
| Q4 2017 | $40,000 | -16.7% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q3 2017 | $48,000 | -15.8% | 20,000 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $57,000 | -44.1% | 20,000 | -90.0% | 0.02% | -42.9% |
| Q1 2017 | $102,000 | +264.3% | 200,000 | 0.0% | 0.03% | +250.0% |
| Q4 2016 | $28,000 | -33.3% | 200,000 | 0.0% | 0.01% | -38.5% |
| Q3 2016 | $42,000 | -16.0% | 200,000 | 0.0% | 0.01% | -18.8% |
| Q2 2016 | $50,000 | -24.2% | 200,000 | 0.0% | 0.02% | -23.8% |
| Q1 2016 | $66,000 | -9.6% | 200,000 | 0.0% | 0.02% | -8.7% |
| Q4 2015 | $73,000 | -40.2% | 200,000 | 0.0% | 0.02% | -39.5% |
| Q2 2015 | $122,000 | – | 200,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 18,340,000 | $3,852,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 9,464,849 | $1,988,000 | 0.07% |
| Northeast Financial Consultants Inc | 150,000 | $31,000 | 0.01% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 200,000 | $42,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 185,239 | $39,000 | 0.01% |
| Benin Management CORP | 93,000 | $20,000 | 0.01% |
| CONDOR CAPITAL MANAGEMENT | 145,000 | $30,000 | 0.01% |
| NIXON PEABODY TRUST CO | 10,000 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 47,677 | $10,000 | 0.00% |
| Renaissance Technologies | 3,201,993 | $672,000 | 0.00% |